Yarlagadda S. Babu
VP Drug Discovery, BioCryst Pharmaceuticals.
Companies
- BioCryst PharmaceuticalsVP Drug Discovery Jan 6, 2009 to Nov 16, 20221
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
BioCryst Pharmaceuticals BCRX298,541 shares2$2.4M at $7.99Nov 14, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 14, 2022Sold 31,515 shares at $13.88 of BioCryst Pharmaceuticals2
- Nov 14, 2022Exercised options 50,000 shares at $1.42 of BioCryst Pharmaceuticals2
- Nov 14, 2022Exercised options 50,000 shares at $1.42 of BioCryst Pharmaceuticals2
- Mar 7, 2022Sold 20,000 shares at $17.16 of BioCryst Pharmaceuticals3
- Dec 14, 2021Granted 35,000 shares of BioCryst Pharmaceuticals4
- Dec 7, 2021Sold 30,100 shares at $12.20 of BioCryst Pharmaceuticals5
- Dec 7, 2021Exercised options 62,000 shares at $4.73 of BioCryst Pharmaceuticals5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Mar 9, 2022
- 4SEC EDGARForm 4 filed Dec 16, 2021
- 5SEC EDGARForm 4 filed Dec 9, 2021